Po-Chang Shih

8PUBLICATIONS
11CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsMolecular targetsIndustrial molecular engineering of nucleic acids and proteinsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 14, 2026
Discovery of phenylacetamide derivatives as novel STAT3 antagonists.

|Feb 28, 2024
STAT3 phosphorylation inhibitor Bt354 exhibits anti-neoplastic activity in glioblastoma multiforme cells.

Yi-Chun Chiang, Padhmavathi Selvam, You-Xuan Liu

|Aug 15, 2023
Development of Ultrapure and Potent Tannic Acids as a Pan-coronal Antiviral Therapeutic.

Po-Chang Shih, Yi-Wen Mao, Jhe-Wei Hu

|Mar 29, 2023
Current Status of Oligonucleotide-Based Protein Degraders.

Po-Chang Shih, Miyako Naganuma, Yosuke Demizu

|Aug 12, 2022
Stellettin B-Induced Oral Cancer Cell Death via Endoplasmic Reticulum Stress-Mitochondrial Apoptotic and Autophagic Signaling Pathway.

Tsu-Jen Kuo, Yen-Hsuan Jean, Po-Chang Shih

|Jul 27, 2022
Sinularin Induces Oxidative Stress-Mediated Apoptosis and Mitochondrial Dysfunction, and Inhibits Angiogenesis in Glioblastoma Cells.

Shih-Yuan Hsu, Zhi-Hong Wen, Po-Chang Shih

Pageof 2

Frequent Collaborators

5 joint publications

Zhi-Hong Wen

3 joint publications

Hsiao-Mei Kuo

1 joint publications

Yen-Po Chen

1 joint publications

Chung-Chih Tseng